Debele Tilahun Ayane, Peng Sydney, Tsai Hsieh-Chih
Graduate Institute of Applied Science and Technology, National Taiwan University of Science and Technology, 106 Taipei, Taiwan.
Department of Chemical Engineering, National Tsing Hua University, 300 Hsinchu, Taiwan.
Int J Mol Sci. 2015 Sep 14;16(9):22094-136. doi: 10.3390/ijms160922094.
Photodynamic therapy (PDT) is a non-invasive combinatorial therapeutic modality using light, photosensitizer (PS), and oxygen used for the treatment of cancer and other diseases. When PSs in cells are exposed to specific wavelengths of light, they are transformed from the singlet ground state (S₀) to an excited singlet state (S₁-Sn), followed by intersystem crossing to an excited triplet state (T₁). The energy transferred from T₁ to biological substrates and molecular oxygen, via type I and II reactions, generates reactive oxygen species, (¹O₂, H₂O₂, O₂*, HO*), which causes cellular damage that leads to tumor cell death through necrosis or apoptosis. The solubility, selectivity, and targeting of photosensitizers are important factors that must be considered in PDT. Nano-formulating PSs with organic and inorganic nanoparticles poses as potential strategy to satisfy the requirements of an ideal PDT system. In this review, we summarize several organic and inorganic PS carriers that have been studied to enhance the efficacy of photodynamic therapy against cancer.
光动力疗法(PDT)是一种非侵入性的联合治疗方式,它利用光、光敏剂(PS)和氧气来治疗癌症及其他疾病。当细胞中的光敏剂暴露于特定波长的光时,它们会从单重基态(S₀)转变为激发单重态(S₁ - Sn),随后通过系间窜越转变为激发三重态(T₁)。通过I型和II型反应,从T₁转移到生物底物和分子氧的能量会产生活性氧(¹O₂、H₂O₂、O₂*、HO*),这些活性氧会导致细胞损伤,进而通过坏死或凋亡导致肿瘤细胞死亡。光敏剂的溶解性、选择性和靶向性是光动力疗法中必须考虑的重要因素。用有机和无机纳米颗粒对光敏剂进行纳米制剂化是满足理想光动力疗法系统要求的一种潜在策略。在这篇综述中,我们总结了几种已被研究用于提高光动力疗法抗癌疗效的有机和无机光敏剂载体。
Int J Mol Sci. 2015-9-14
Mater Sci Eng C Mater Biol Appl. 2020-10
Curr Drug Discov Technol. 2011-9
Trends Biotechnol. 2008-11
Cancer Lett. 2012-9-24
Curr Drug Metab. 2009-10
Photodiagnosis Photodyn Ther. 2018-3-26
ACS Appl Mater Interfaces. 2019-11-19
J Mater Chem B. 2014-7-14
Materials (Basel). 2013-3-6
Pharmaceuticals (Basel). 2010-5-14
Nanoscale Res Lett. 2011-12
Nanotechnol Rev. 2012-3
Photochem Photobiol Sci. 2015-8
ACS Biomater Sci Eng. 2015